Advertisement
Advertisement
LUNG
Pulmonx Corporation Common Stock
1.26
USDSponsored
-0.01
-0.79%
May 08, 15:52 UTC -4
Closed
After-Market
1.30
+0.04
+3.25%
LUNG Earnings Reports
Positive Surprise Ratio
LUNG beat 22 of 23 last estimates.
96%
Next Report
Date of Next Report
Jul 28, 2026
Estimate for Q2 26 (Revenue/ EPS)
$22.87M
/-$0.28
Implied change from Q1 26 (Revenue/ EPS)
+11.07%
/-15.15%
Implied change from Q2 25 (Revenue/ EPS)
-4.17%
/-26.32%
Pulmonx Corporation Common Stock earnings per share and revenue
On Apr 29, 2026, LUNG reported earnings of -0.33 USD per share (EPS) for Q1 26, beating the estimate of -0.33 USD, resulting in a 0.96% surprise. Revenue reached 20.59 million, compared to an expected 20.84 million, with a -1.22% difference. The market reacted with a +6.67% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 8 analysts forecast an EPS of -0.28 USD, with revenue projected to reach 22.87 million USD, implying an decrease of -15.15% EPS, and increase of 11.07% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Enovis Corporation
Report Date
May 07, 2026 For Q1 26
Estimate
$0.83
Actual
$0.89
Surprise
+6.65%
Clover Health Investments, Corp
Report Date
May 06, 2026 For Q1 26
Estimate
$0.03
Actual
$0.07
Surprise
+128.76%
Claritev Corporation
Report Date
May 07, 2026 For Q1 26
Estimate
-$4.08
Actual
-$4.41
Surprise
-7.90%
Evolent Health, Inc Class A Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.05
Actual
-$0.02
Surprise
+61.39%
KORU Medical Systems, Inc. Common Stock (DE)
Report Date
May 06, 2026 For Q1 26
Estimate
-$0.02
Actual
-$0.02
Surprise
+1.96%
CareCloud, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
$0.00
Actual
$0.05
Surprise
+835.29%
American Well Corporation
Report Date
May 05, 2026 For Q1 26
Estimate
-$1.18
Actual
-$0.78
Surprise
+33.98%
Outset Medical, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.81
Actual
-$0.83
Surprise
-2.00%
10x Genomics, Inc. Class A Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.29
Actual
-$0.10
Surprise
+66.04%
Privia Health Group, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
$0.07
Actual
$0.02
Surprise
-73.72%
FAQ
What were Pulmonx Corporation Common Stock's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Pulmonx Corporation Common Stock reported EPS of -$0.33, beating estimates by 0.96%, and revenue of $20.59M, -1.22% below expectations.
How did the market react to Pulmonx Corporation Common Stock's Q1 2026 earnings?
The stock price moved up 6.67%, changed from $1.20 before the earnings release to $1.28 the day after.
When is Pulmonx Corporation Common Stock expected to report next?
The next earning report is scheduled for Jul 28, 2026.
What are the forecasts for Pulmonx Corporation Common Stock's next earnings report?
Based on 8
analysts, Pulmonx Corporation Common Stock is expected to report EPS of -$0.28 and revenue of $22.87M for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement